Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
Latest Hotspot
8 min read
JPRN-jRCT2033250788 HLC-001 Ichthyosis Prematurity Syndrome Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
17 August 2026
JPRN-jRCT2033250788 clinical trial report covering HLC-001, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07457918 Cantharidin Condylomata Acuminata Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
17 August 2026
NCT07457918 clinical trial report covering Cantharidin, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07461948 Ferumoxytol Glioblastoma Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
17 August 2026
NCT07461948 clinical trial report covering Ferumoxytol, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07457294 Clascoterone Acne Vulgaris Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
17 August 2026
NCT07457294 clinical trial report covering Clascoterone, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
CTR20260756 Group ACYW135 Meningococcal Conjugate Vaccine (Sinovac Life Sciences) Meningitis Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
17 August 2026
CTR20260756 clinical trial report covering Group ACYW135 Meningococcal Conjugate Vaccine (Sinovac Life Sciences), Phase 3, endpoints, sponsor, geography, r
Latest Hotspot
8 min read
NCT07461441 Faricimab Age Related Macular Degeneration Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
17 August 2026
NCT07461441 clinical trial report covering Faricimab, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07461454 YL-202 Locally advanced breast cancer Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
17 August 2026
NCT07461454 clinical trial report covering YL-202, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
CTR20260784 Bufei Huoxue Capsule Pulmonary Disease, Chronic Obstructive Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
17 August 2026
CTR20260784 clinical trial report covering Bufei Huoxue Capsule, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07461675 Atezolizumab Hepatocellular Carcinoma Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
17 August 2026
NCT07461675 clinical trial report covering Atezolizumab, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
CTR20260900 Beclometasone Dipropionate/Formoterol Fumarate Asthma Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
17 August 2026
CTR20260900 clinical trial report covering Beclometasone Dipropionate/Formoterol Fumarate, Phase 3, endpoints, sponsor, geography, readout timing and devel
Latest Hotspot
8 min read
CTR20260844 H062 Essential Hypertension Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
17 August 2026
CTR20260844 clinical trial report covering H062, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
ChiCTR2600120216 Eptifibatide occlusions Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
17 August 2026
ChiCTR2600120216 clinical trial report covering Eptifibatide, Phase 3, endpoints, sponsor, geography, readout timing and development white space.